發(fā)布時(shí)間：2018-10-20 19:37

【摘要】：正阿德福韋酯是一種核苷酸類抗乙型肝炎病毒(HBV)藥物,對(duì)耐拉米夫定的HBV具有良好活性,其作用溫和,應(yīng)用廣泛。長(zhǎng)期服用阿德福韋酯可以導(dǎo)致低磷性骨軟化癥,臨床醫(yī)師往往對(duì)此認(rèn)識(shí)不足,造成誤診誤治。本文報(bào)道1例阿德福韋酯致低磷性骨軟化癥,總結(jié)該不良反應(yīng)的特點(diǎn),為臨床安全用藥提供參考。
[Abstract]:Orthoadefovir ester is a kind of nucleotide anti-HBV (HBV) drug, which has good activity against HBV of lamivudine, and its effect is mild and widely used. Long-term administration of adefovir can lead to low-phosphorous osteomalacia, which is often poorly understood by clinicians and misdiagnosed and mistreated. A case of low phosphorus osteomalacia induced by adefovir ester was reported.
【作者單位】： 鄭州大學(xué)第一附屬醫(yī)院藥劑科;
【分類號(hào)】：R512.62

【相似文獻(xiàn)】

相關(guān)期刊論文 前1條

1 袁樂(lè)媛;王柏芳;王炳元;韓慧芳;高君;唐芳馨;李雪華;;阿德福韋酯誘發(fā)范可尼綜合征和骨軟化癥病例報(bào)告和誤診分析[J];傳染病信息;2013年02期

，

本文編號(hào)：2284181